This is a non-core endpoint: only basic statistics are computed.
Leiomyosarcoma
C3_LEIOMYOSARCOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
275 |
4. Check minimum number of eventsNone |
275 |
5. Include endpointsNone |
275 |
6. Filter based on genotype QC (FinnGen only) |
266 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Leiomyosarcoma
based on the number of shared cases.
Similar with more cases:
- Leiomyosarcoma, including Hilmo
- Solid cancers
- Malignant neoplasm
- Malignant neoplasm
- Solid cancers, including Hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 266 | 180 | 86 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.04 |
| Median age at first event (years) | 60.56 | 58.07 | 65.77 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 275
- Matched controls
- 2750
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
126.1
200.7
103
13
JN4AD
NOMESCO Finland
Body CT examination
18.8
106.9
99
80
A04AA01
ATC
ondansetron; systemic, rectal
28.8
105.4
76
36
130
Kela drug reimbursment
Malignant tumour
+∞
100.3
90
*
A03FA01
ATC
metoclopramide; systemic, rectal
10.9
88.3
138
233
Z51.5
ICD-10 Finland
Palliative care
19.1
88.0
77
55
C54.21
ICD-10 Finland
Leiomyosarcoma and myometrium
+∞
87.2
79
*
JN4BD
NOMESCO Finland
Extensive body CT
17.7
84.6
77
59
XX3DW
NOMESCO Finland
Time consuming IT work
17.7
77.9
70
52
TPX10
NOMESCO Finland
Implantation of vascular injection port
33.1
70.8
47
17
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
809.0
66.9
63
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
23.6
64.8
49
25
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.6
64.4
47
22
L03AA13
ATC
pegfilgrastim; parenteral
391.6
63.2
61
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
56.2
52
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
52.8
49
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
52.8
49
*
N02AA05
ATC
oxycodone; systemic
6.3
48.3
116
286
159
Kela drug reimbursment
Pazopanib
+∞
45.0
42
*
L03AA02
ATC
filgrastim; parenteral
+∞
45.0
42
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
503.3
44.5
43
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
43.9
41
*
A04AA02
ATC
granisetron; systemic, transdermal
489.3
43.4
42
*
B01AB10
ATC
tinzaparin; parenteral
7.4
43.2
75
133
C49.23
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip leiomyosarcoma
+∞
42.8
40
*
8890/3-C54.9
ICD-O-3
Leiomyosarcoma, NOS, of corpus uteri
+∞
42.8
40
*
C54.2
ICD-10 Finland
Malignant neoplasm: Myometrium
+∞
42.8
40
*
8890/3-C54.2
ICD-O-3
Leiomyosarcoma, NOS, of myometrium
+∞
42.8
40
*
8890/3-C49.2
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
41.7
39
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.9
41.7
53
65
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
15.0
40.8
38
29
WZC00
NOMESCO Finland
Treatment plan or consultation
4.9
37.4
137
467
L02BG04
ATC
letrozole; oral
206.2
35.7
36
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
35.2
33
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
193.1
33.5
34
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
33.0
31
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
10.8
32.2
37
39
LCD00
NOMESCO Finland
Hysterectomy
8.3
32.0
46
65
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
13.3
31.3
31
26
C48.03
ICD-10 Finland
Malignant tumor of the retroperitoneal space leiomyosarcoma
+∞
30.8
29
*
WZC30
NOMESCO Finland
Teaching
5.2
30.3
76
187
A04AD12
ATC
aprepitant; systemic
+∞
29.7
28
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
28.6
27
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
10.8
27.3
31
32
B01AB05
ATC
enoxaparin; parenteral
3.8
26.8
139
580
343
Kela drug reimbursment
Pazopanib
+∞
26.5
25
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
286.0
26.2
26
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
24.3
23
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
24.3
23
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.9
23.9
35
50
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
9.7
23.7
29
33
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
7.3
22.3
35
54
L01EX03
ATC
pazopanib; oral
+∞
22.2
21
*
C49.43
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen leiomyosarcoma
+∞
22.2
21
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
22.2
21
*
WF002
NOMESCO Finland
Radical radiotherapy
87.4
22.0
24
*
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
238.2
21.9
22
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.6
21.6
99
372
L01XE11
ATC
[U] pazopanib
+∞
21.1
20
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
21.1
20
*
JN4CD
NOMESCO Finland
Very extensive body CT
25.8
20.4
28
12
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
20.0
19
*
8890/3-C49.1
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
20.0
19
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.7
20.0
34
57
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
113.3
19.8
21
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
59.5
19.2
22
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
19.0
18
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
19.0
18
*
8890/3-C48.0
ICD-O-3
Leiomyosarcoma, NOS, of retroperitoneum
+∞
17.9
17
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
17.9
17
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
17.9
17
*
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
4.2
17.6
53
147
WW500
NOMESCO Finland
Blood transfusion
16.3
17.6
28
19
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
17.5
170
962
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
15.4
17.2
28
20
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
16.8
16
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
16.8
16
*
C49.13
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder leiomyosarcoma
+∞
16.8
16
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
16.8
16
*
ZZR00
NOMESCO Finland
Flap of skin
96.0
16.8
18
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
180.5
16.7
17
*
ZX120
NOMESCO Finland
Intravenous
5.6
16.7
34
68
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
32.3
16.4
21
7
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
13.4
16.3
28
23
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
15.8
15
*
A79
ICPC
Malignancy NOS
+∞
15.8
15
*
8890/3-C49.4
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
15.8
15
*
115
Kela drug reimbursment
Breast cancer
+∞
15.8
15
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
15.8
15
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.8
15.4
53
161
C49.53
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis leiomyosarcoma
+∞
14.7
14
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.6
14.5
54
173
ZX090
NOMESCO Finland
Other technic of radiotherapy
56.4
14.0
16
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.9
13.9
22
34
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
13.7
13
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
13.7
13
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
13.7
13
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
13.7
13
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
13.7
13
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
13.7
13
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
13.7
13
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
13.7
13
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.0
13.4
42
119
GD1AD
NOMESCO Finland
Thorax CT examination
4.9
13.2
31
70
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
13.1
69
273
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
13.2
12.9
22
18
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.0
12.8
39
108
S18
ICPC
Laceration/cut
2.5
12.8
159
964
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
12.6
12
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.6
12
*
WX402
NOMESCO Finland
General anaesthesia
2.9
12.5
71
292
B01AB04
ATC
dalteparin; parenteral
5.5
12.5
25
49
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
67.9
11.7
13
*
C49.83
ICD-10 Finland
Overall malignant tumor of connective tissue and other soft tissue leiomyosarcoma
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
11.5
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
JAH00
NOMESCO Finland
Laparotomy
9.9
11.2
22
24
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
5.0
11.2
25
54
R50.9
ICD-10 Finland
Fever, unspecified
3.0
10.7
56
219
ZXE20
NOMESCO Finland
More than three and less than five hours
3.1
10.6
50
184
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
10.5
46
162
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
12.7
10.5
18
15
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
12.7
10.5
18
15
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
114.2
10.5
11
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
10.5
10
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
10.5
10
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.5
10
*
C49.33
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the chest leiomyosarcoma
+∞
10.5
10
*
8890/3-C55.9
ICD-O-3
Leiomyosarcoma, NOS, of uterus, NOS
+∞
10.5
10
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
10.5
10
*
C54.12
ICD-10 Finland
Adenosquamous carcinoma of the endometrium
+∞
10.5
10
*
C49.03
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck Leiomyosarcoma
+∞
10.5
10
*
C03CA01
ATC
furosemide; systemic
2.3
10.2
120
690
XX2RW, ,
NOMESCO Finland
41.7
10.0
12
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
17.5
10.0
15
9
SPAT1255
SPAT
Intravenous administration of medicine
4.2
9.9
28
73
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
9.9
60
253
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
10.1
9.9
19
20
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
57.1
9.7
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
103.4
9.5
10
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
103.4
9.5
10
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
103.4
9.5
10
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
103.4
9.5
10
*
8890/3-C49.5
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of pelvis
+∞
9.4
9
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
9.4
9
*
X77
ICPC
Malignant neopl genital female other
+∞
9.4
9
*
WZC15, ,
NOMESCO Finland
+∞
9.4
9
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
9.4
9
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
9.4
9
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
9.4
9
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
9.3
111
637
A06AH03
ATC
naloxegol; oral
38.0
9.1
11
*
SPAT1153
SPAT
Removal of sutures
2.2
9.1
103
579
B02AA02
ATC
tranexamic acid; systemic
2.7
8.9
56
240
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.2
8.5
23
58
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.6
8.5
29
87
KAC00
NOMESCO Finland
Nephrectomy
92.8
8.5
9
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
8.4
42
159
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.9
8.4
16
17
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
8.4
8
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
8.4
8
*
C49.63
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the torso, unspecified localization leiomyosarcoma
+∞
8.4
8
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
8.4
8
*
1820C
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[SARCOMA MYOMETRI]
+∞
8.4
8
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
8.4
8
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
8.4
8
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
8.4
8
*
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
8.4
8
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
8.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
8890/3-C64.9
ICD-O-3
Leiomyosarcoma, NOS, of kidney, NOS
+∞
8.4
8
*
C54.29
ICD-10 Finland
Unspecified uterine sarcoma
+∞
8.4
8
*
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
8.4
8
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
8.4
8
*
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
7.9
8.3
18
24
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.8
8.3
19
42
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
8.2
42
161
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.2
8.2
19
28
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
7.2
8.2
19
28
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
12.2
8.2
14
12
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
10.5
8.1
15
15
JAL00
NOMESCO Finland
Biopsy of peritoneum
22.8
8.1
11
5
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.6
8.0
28
85
JFB30
NOMESCO Finland
Right hemicolectomy
46.3
7.8
9
*
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
46.3
7.8
9
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
46.3
7.8
9
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.0
7.7
22
58
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
25.8
7.6
10
*
ZZA00
NOMESCO Finland
Split skin graft
8.0
7.5
16
21
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
82.2
7.5
8
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
82.2
7.5
8
*
8890/3-C44.7
ICD-O-3
Leiomyosarcoma, NOS, of skin of lower limb and hip
+∞
7.3
7
*
8890/3-C49.6
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
+∞
7.3
7
*
YX9AW, ,
NOMESCO Finland
+∞
7.3
7
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
7.3
7
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
7.3
7
*
8890/3-C44.6
ICD-O-3
Leiomyosarcoma, NOS, of skin of upper limb and shoulder
+∞
7.3
7
*
C49.93
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue leiomyosarcoma
+∞
7.3
7
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
+∞
7.3
7
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
+∞
7.3
7
*
UKC02
NOMESCO Finland
Cystoscopy
2.5
7.2
49
218
S77
ICPC
Malignant neoplasm of skin
71.4
6.5
7
*
J01MA12
ATC
levofloxacin; systemic
2.3
6.3
56
279
JFB00
NOMESCO Finland
Partial resection of small intestine
18.5
6.3
9
5
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
6.3
6
*
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
6.3
6
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
6.3
6
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
+∞
6.3
6
*
JLC10
NOMESCO Finland
Distal pancreatectomy
+∞
6.3
6
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
6.3
6
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
6.3
6
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
6.3
6
*
8890/3-C49.9
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
6.3
6
*
YJ3VG
NOMESCO Finland
MRI examination of abdomen with high intesity magnet for dose design of radiotherapy
+∞
6.3
6
*
L02AB02
ATC
medroxyprogesterone; systemic
27.4
6.3
8
*
R4190
NOMESCO Finland
Nutritional therapy
6.5
6.3
15
24
M05BX04
ATC
denosumab; parenteral
2.9
6.3
30
111
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
8.9
6.1
12
14
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
69
124
7.09
38.98
2.2
1.5
2.68
2.59
ug/l
0.09
48
94
190
988
3.99
25.94
3.9
2.5
—
—
estimate
—
0
0
204
1224
3.58
19.99
21.3
6.3
4.09
4.24
e9/l
0.31
184
1046
117
517
3.20
19.23
3.3
2.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
56
6.56
19.19
2.6
2.7
0.35
0.42
iu/ml
0.37
17
34
180
1031
3.16
18.49
8.1
3.9
34.00
35.60
g/l
2.99
171
968
177
1057
2.89
15.90
9.2
6.3
1.21
1.21
mmol/l
0.49
168
954
187
1195
2.77
13.96
9.3
6.8
1.21
1.21
mmol/l
0.78
156
1037
178
1123
2.66
13.41
18.6
15.7
1.29
1.27
inr
0.18
155
934
85
404
2.60
11.22
2.0
1.8
—
—
—
0
0
45
151
3.37
11.15
8.7
8.2
24.42
25.34
mmol/l
0.82
45
151
228
1753
2.76
9.55
20.0
5.5
93.95
78.61
u/l
4.65
223
1627
43
155
3.10
9.43
1.8
1.6
—
—
—
0
0
72
343
2.49
9.27
4.6
1.7
30.52
29.44
s
0.60
72
333
24
59
4.36
9.18
1.9
1.4
—
—
—
0
0
133
827
2.18
9.10
10.1
2.1
2.36
2.36
mmol/l
0.05
126
730
207
1548
2.36
8.75
6.3
4.8
195.14
4321.38
e6/l
—
7
24
66
312
2.47
8.59
1.7
1.8
—
—
—
0
0
61
285
2.47
8.11
7.9
9.1
0.29
1.54
mmol/l
2.36
48
245
61
295
2.37
7.48
1.8
1.8
—
—
—
0
0
17
25
7.17
7.41
1.7
1.6
3.42
150.89
u/ml
0.48
17
25
51
238
2.40
6.73
3.3
2.2
10.91
5.90
umol/l
0.69
45
208
89
521
2.05
6.72
6.7
2.2
2.48
2.44
mmol/l
1.52
82
470
118
767
1.94
6.58
3.1
2.3
56.21
65.13
u/l
0.68
111
707
49
231
2.36
6.31
6.4
3.3
—
—
—
0
0
6
0
+∞
6.27
1.0
0.0
22.88
—
u/ml
—
6
0
103
651
1.93
6.16
3.7
3.1
0.56
0.46
e6/l
0.17
82
476
114
757
1.86
5.79
6.2
2.7
42.78
34.45
u/l
0.56
106
712
11
15
7.59
5.19
1.6
1.3
—
—
—
0
0
13
23
5.88
5.13
1.2
1.2
—
—
—
0
0
13
25
5.40
4.83
1.7
1.2
—
—
—
0
0
15
35
4.47
4.70
1.5
1.2
—
—
—
0
0
7
5
14.31
4.60
1.9
1.6
1.93
2.00
%
—
7
5
8
8
10.25
4.55
1.5
1.1
—
—
—
0
0
12
23
5.40
4.51
1.6
1.3
—
—
—
0
0
118
841
1.71
4.42
3.0
3.2
2417.97
1471.80
ng/l
1.15
105
713
30
133
2.41
4.41
1.4
1.5
—
—
—
0
0
15
45
3.47
4.39
4.3
3.1
4.71
5.19
kpa
1.41
15
45
8
9
9.11
4.31
1.5
1.1
—
—
—
0
0
8
9
9.11
4.31
1.5
1.1
—
—
—
0
0
7
6
11.92
4.30
4.4
1.2
5.79
4.15
nmol/l
—
7
6
68
1022
0.56
4.25
1.8
1.9
1.42
1.30
mmol/l
0.49
50
860
68
423
1.81
4.06
3.5
2.8
1.17
1.41
e6/l
0.35
44
215
57
338
1.87
3.95
3.2
2.5
20.81
22.38
%
0.40
52
310
19
72
2.76
3.82
2.0
3.7
—
—
—
0
0
7
8
8.94
3.79
2.6
2.5
—
—
—
0
0
7
8
8.94
3.79
1.1
1.5
—
—
—
0
0
61
375
1.81
3.76
3.8
3.0
4.43
3.50
e6/l
0.26
35
166
16
56
2.97
3.69
1.5
1.2
—
—
—
0
0
30
147
2.17
3.52
2.2
1.6
—
—
—
0
0
6
6
10.18
3.51
1.0
1.3
—
1.02
—
0
6
22
446
0.45
3.34
1.3
1.3
21.21
14.66
u/ml
0.15
14
175
21
90
2.44
3.33
2.3
1.7
—
—
—
0
0
25
482
0.47
3.31
1.3
1.3
15.89
37.82
iu/ml
—
7
143
15
54
2.88
3.31
1.5
1.2
—
—
—
0
0
11
31
3.65
3.02
1.5
1.1
—
—
—
0
0
97
714
1.55
2.94
4.5
4.0
0.00
0.00
estimate
-0.00
36
230
248
2262
1.98
2.94
33.4
14.6
31.52
23.15
mg/l
3.31
236
1813
15
58
2.68
2.92
1.5
1.3
245.40
318.62
ug/g
—
10
33
12
38
3.25
2.89
1.5
1.2
—
—
—
0
0
6
9
6.78
2.88
2.7
2.0
14.67
15.33
%
—
6
9
8
18
4.54
2.81
1.1
1.0
—
—
—
0
0
5
6
8.46
2.76
5.6
1.0
65.40
78.67
nmol/l
—
5
6
12
40
3.09
2.73
1.5
1.1
—
—
—
0
0
35
200
1.86
2.72
6.7
7.5
9.97
10.91
mmol/l
0.40
35
188
86
627
1.54
2.69
2.1
2.3
2.93
2.83
mg/l
0.18
72
537
7
15
4.76
2.61
1.3
1.1
—
—
—
0
0
35
203
1.83
2.60
2.0
4.1
154.31
239.72
ng/l
0.84
29
185
174
1473
1.49
2.60
4.6
3.2
75.38
47.83
u/l
1.99
165
1368
44
276
1.71
2.52
3.3
3.1
2.09
2.28
mmol/l
0.13
36
243
12
45
2.74
2.48
1.5
1.1
—
—
—
0
0
13
51
2.63
2.48
1.8
2.3
1.69
1.77
mg/l
0.15
13
44
153
1273
1.46
2.42
4.1
4.0
0.00
0.00
estimate
-0.00
37
249
154
1289
1.44
2.33
4.1
4.0
0.00
0.00
estimate
-0.00
37
252
155
1299
1.44
2.33
4.2
4.1
0.00
0.03
estimate
0.93
35
239
9
29
3.17
2.24
1.0
1.2
—
329.40
—
0
5
8
24
3.40
2.19
1.3
1.0
—
—
—
0
0
24
131
1.91
2.16
3.9
4.0
1.02
2.53
mmol/l
0.70
19
94
8
25
3.26
2.11
1.3
1.0
—
—
—
0
0
8
25
3.26
2.11
1.3
1.0
—
—
—
0
0
17
85
2.07
1.95
4.5
4.7
24.40
25.12
mmol/l
0.33
17
79
8
28
2.91
1.87
1.1
1.0
—
—
—
0
0
8
28
2.91
1.87
1.3
1.0
—
—
—
0
0
8
28
2.91
1.87
1.3
1.0
—
—
—
0
0
17
87
2.02
1.84
2.4
1.6
—
—
—
0
0
238
2209
1.58
1.81
36.3
13.9
75.53
76.08
ml/min/173m2
0.17
233
2037
29
181
1.67
1.72
5.0
1.9
59.76
62.78
ml/min/173m2
0.21
17
64
6
20
3.04
1.59
1.5
1.2
—
—
—
0
0
5
15
3.37
1.53
1.4
1.7
—
—
—
0
0
5
15
3.37
1.53
1.4
1.7
—
—
—
0
0
12
58
2.12
1.51
1.4
1.6
—
—
—
0
0
121
1024
1.32
1.49
4.3
4.1
28.67
68.33
ng/l
0.67
104
766
68
532
1.37
1.40
1.9
1.7
1.83
1.03
mg/l
1.14
51
423
0
40
0.00
1.33
0.0
1.4
—
—
—
0
0
6
24
2.53
1.31
1.0
1.1
—
—
—
0
0
9
44
2.08
1.28
1.3
1.4
—
—
—
0
0
9
44
2.08
1.28
1.3
1.4
—
—
—
0
0
222
2342
0.73
1.21
5.4
6.3
2.58
2.68
mmol/l
0.78
202
2161
114
983
1.27
1.15
4.5
4.0
0.00
0.02
estimate
0.80
29
202
33
235
1.46
1.15
1.6
2.7
11.70
7.79
ug/l
0.19
26
202
12
65
1.88
1.15
1.6
1.4
—
—
—
0
0
202
1869
1.30
1.14
5.3
4.4
14.88
14.88
pmol/l
0.00
188
1701
8
41
1.98
1.09
1.5
1.1
—
—
—
0
0
7
33
2.15
1.06
1.3
1.5
—
—
—
0
0
74
615
1.28
0.99
2.8
2.3
346.58
348.69
umol/l
0.06
65
532
248
2379
1.43
0.98
37.5
18.5
139.29
139.84
mmol/l
1.94
248
2331
248
2380
1.43
0.97
37.8
18.6
3.99
3.99
mmol/l
0.03
248
2329
0
31
0.00
0.97
0.0
1.2
—
6.77
—
0
22
15
94
1.63
0.92
4.9
2.1
477.13
770.37
ug/l
0.27
15
89
40
309
1.34
0.91
6.1
7.1
—
—
—
0
0
6
29
2.09
0.90
1.3
1.0
—
—
—
0
0
213
2238
0.79
0.88
7.3
6.9
42.15
39.79
mmol/mol
2.09
191
2097
6
31
1.96
0.85
1.2
1.4
—
—
—
0
0
26
347
0.72
0.81
1.5
1.4
—
—
—
0
0
65
546
1.25
0.80
1.7
1.7
509.28
453.19
pmol/l
0.38
47
445
219
2287
0.79
0.79
4.6
5.4
1.49
1.54
mmol/l
0.86
198
2107
221
2302
0.80
0.74
4.7
5.5
4.52
4.65
mmol/l
1.02
201
2131
58
486
1.25
0.73
4.2
4.5
24.43
289.14
ng/l
1.90
49
395
9
56
1.63
0.73
1.6
1.9
—
—
—
0
0
7
40
1.77
0.72
1.0
1.3
439.43
374.29
pmol/l
—
7
34
5
26
1.94
0.71
1.2
1.2
—
—
—
0
0
77
671
1.20
0.67
4.3
3.5
0.00
0.00
estimate
-0.00
28
197
10
154
0.64
0.66
1.6
1.7
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
42.51
—
0
14
0
23
0.00
0.58
0.0
1.0
—
537.43
—
0
14
70
616
1.18
0.55
4.4
4.0
1.02
1.02
kg/l
1.03
47
398
11
74
1.51
0.54
1.1
1.2
—
—
—
0
0
11
74
1.51
0.54
1.1
1.2
—
—
—
0
0
9
136
0.65
0.53
1.4
1.6
—
—
—
0
0
19
144
1.34
0.52
3.2
2.2
0.58
0.62
%
0.28
19
144
249
2428
1.27
0.51
44.8
19.5
80.58
77.67
umol/l
0.81
249
2395
19
145
1.33
0.50
3.2
2.3
1.21
1.17
%
0.07
19
145
10
68
1.49
0.47
1.2
1.2
—
—
—
0
0
7
48
1.47
0.47
1.4
1.8
—
—
—
0
0
5
81
0.61
0.46
4.6
1.3
0.00
0.00
g/l
—
5
75
39
333
1.20
0.44
3.9
2.9
0.70
0.79
ug/l
0.48
32
214
23
186
1.26
0.42
2.7
2.7
122.70
129.24
g/l
1.02
23
180
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
2.4
—
13.68
—
0
18
184
1911
0.89
0.38
41.1
19.1
329.66
331.29
g/l
1.75
184
1900
10
72
1.40
0.37
1.4
1.2
—
—
—
0
0
16
126
1.29
0.36
3.4
3.4
4.29
4.48
pmol/l
0.52
16
113
10
74
1.36
0.32
1.7
1.5
—
—
—
0
0
10
74
1.36
0.32
1.3
1.5
—
—
—
0
0
190
1836
1.11
0.32
41.5
18.2
14.58
13.62
%
11.72
190
1810
223
2282
0.88
0.32
5.2
5.4
6.22
5.99
mmol/l
1.10
202
2091
38
336
1.15
0.30
1.3
1.4
—
—
—
0
0
51
461
1.13
0.30
6.0
4.1
18.68
25.30
%
4.06
34
226
47
520
0.88
0.29
1.2
1.3
0.93
1.48
u/ml
0.68
16
155
104
1100
0.91
0.28
2.5
2.5
79.01
79.18
nmol/l
0.02
91
974
84
787
1.10
0.26
1.6
1.7
20.36
20.43
nmol/l
0.01
71
669
250
2464
1.16
0.25
50.2
22.2
92.07
91.35
fl
1.48
250
2432
250
2465
1.16
0.24
51.5
22.7
37.79
40.06
%
10.93
250
2432
250
2465
1.16
0.24
50.8
22.4
124.89
134.17
g/l
17.25
250
2433
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
151.47
—
0
10
214
2181
0.92
0.21
4.2
4.7
1.33
1.26
mmol/l
0.87
189
1992
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
131
1270
1.06
0.16
2.6
2.7
—
—
—
0
0
12
103
1.17
0.14
1.1
1.3
—
—
—
0
0
111
1080
1.05
0.11
3.0
3.0
166.39
107.44
ug/l
1.90
103
1000
112
1150
0.96
0.11
2.1
2.2
90.77
98.44
pmol/l
0.95
63
563
220
2179
1.05
0.08
6.3
5.6
2.10
1.94
mu/l
0.65
203
1998
5
64
0.78
0.08
2.0
1.5
—
—
—
0
0
13
117
1.12
0.08
1.0
1.0
—
—
—
0
0
180
1782
1.03
0.06
4.1
4.4
17.47
12.64
mm/h
2.18
158
1640
88
895
0.98
0.04
4.3
3.9
7.46
7.30
mg/mmol
0.02
54
541
32
314
1.02
0.00
4.7
5.3
32.86
33.18
%
0.06
22
200
19
192
0.99
0.00
1.5
1.4
—
—
—
0
0
48
484
0.99
0.00
1.9
1.7
1342.69
1205.24
nmol/l
0.42
32
376
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
69
0.87
0.00
1.0
1.3
561.00
508.33
mg/l
—
6
64
0
6
0.00
0.00
0.0
11.2
—
11.02
—
0
6
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
6.90
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
43.52
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
37.95
—
0
8
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_LEIOMYOSARCOMA – Leiomyosarcoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).